NOVARTIS PHARMA AG
- Country
- Switzerland
- Type
- Beneficiary
- Website
- www.novartis.com
- Grants received
- 56
Funding record
- 56 grants on record
- €2,998,017.32 awarded in total
- 2008–2025 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
44 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- JANSSEN PHARMACEUTICA NV
- GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
- BAYER AKTIENGESELLSCHAFT
- ELI LILLY AND COMPANY LTD
- ASTRAZENECA AB
- SANOFI-AVENTIS RECHERCHE & DEVELOPPEMENT
- KATHOLIEKE UNIVERSITEIT LEUVEN
Calls from this organisation
No published calls from this organisation.
Grants received
- Asymmetric carbyne catalytic transfer to streamline synthesis of chiral β-amino carbonyls
- Research in Europe and Diversity Inclusion
- Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models
- Metal-containing Radical Enzymes
- European platform for neurodegenerative disorders
- Health Initiatives in Psoriasis and PsOriatic arthritis ConsoRTium European States
- H2O Health Outcomes Observatory
- Prioritisation and Risk Evaluation of Medicines in the EnviRonment
- C-H Activation for Industrial Renewal
- Translational approaches to disease modifying therapy of type 1 diabetes - HARVESTing the fruits of INNODIA
- PharmaLedger
- Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies
- Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies
- EU Patient- cEntric clinicAl tRial pLatform
- Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.